192 related articles for article (PubMed ID: 31455338)
41. Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease.
Berg J; Halvorsen AR; Bengtson MB; Taskén KA; Mælandsmo GM; Yndestad A; Halvorsen B; Brustugun OT; Aukrust P; Ueland T; Helland Å
BMC Cancer; 2018 Jul; 18(1):739. PubMed ID: 30005623
[TBL] [Abstract][Full Text] [Related]
42. Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer.
Beeh KM; Beier J; Ernst M; Kornmann O; Buhl R
Respiration; 2003; 70(2):166-71. PubMed ID: 12740514
[TBL] [Abstract][Full Text] [Related]
43. Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts.
Valvi D; Mannino DM; Müllerova H; Tal-Singer R
Int J Chron Obstruct Pulmon Dis; 2012; 7():173-82. PubMed ID: 22419864
[TBL] [Abstract][Full Text] [Related]
44. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients.
Li X; Wang T; Yang T; Shen Y; An J; Liu L; Dong J; Guo L; Li D; Zhang X; Chen L; Xu D; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():587-94. PubMed ID: 25844034
[TBL] [Abstract][Full Text] [Related]
45. Imbalance of dendritic cell co-stimulation in COPD.
Stoll P; Ulrich M; Bratke K; Garbe K; Virchow JC; Lommatzsch M
Respir Res; 2015 Feb; 16(1):19. PubMed ID: 25775429
[TBL] [Abstract][Full Text] [Related]
46. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic Utility of Biomarkers in COPD.
Ambade VN; Sontakke AN; Barthwal MS; Tyagi R; Basannar DR
Respir Care; 2015 Dec; 60(12):1729-42. PubMed ID: 26106205
[TBL] [Abstract][Full Text] [Related]
48. Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?
Pleguezuelos E; Esquinas C; Moreno E; Guirao L; Ortiz J; Garcia-Alsina J; Merí A; Miravitlles M
Lung; 2016 Apr; 194(2):249-57. PubMed ID: 26743191
[TBL] [Abstract][Full Text] [Related]
49. Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease.
Karadeniz G; Aktoğu S; Erer OF; Kır SB; Doruk S; Demir M; Sonat K
Biomark Med; 2016 Jul; 10(7):701-10. PubMed ID: 27339097
[TBL] [Abstract][Full Text] [Related]
50. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
51. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
52. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?
Andelid K; Tengvall S; Andersson A; Levänen B; Christenson K; Jirholt P; Åhrén C; Qvarfordt I; Ekberg-Jansson A; Lindén A
Int J Chron Obstruct Pulmon Dis; 2015; 10():689-702. PubMed ID: 25848245
[TBL] [Abstract][Full Text] [Related]
53. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).
Pastor MD; Nogal A; Molina-Pinelo S; Quintanal-Villalonga Á; Meléndez R; Ferrer I; Romero-Romero B; De Miguel MJ; López-Campos JL; Corral J; García-Carboner R; Carnero A; Paz-Ares L
J Thorac Oncol; 2016 Dec; 11(12):2183-2192. PubMed ID: 27524264
[TBL] [Abstract][Full Text] [Related]
54. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases.
Kondo R; Yoshida K; Eguchi T; Kobayashi N; Saito G; Hamanaka K; Shiina T; Kurai M
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1439-43. PubMed ID: 21530296
[TBL] [Abstract][Full Text] [Related]
55.
Zhang LY; Sun XW; Ding YJ; Yan YR; Wang Y; Li CX; Li SQ; Zhang L; Song HJ; Li HP; Li QY
Int J Chron Obstruct Pulmon Dis; 2022; 17():2117-2125. PubMed ID: 36097589
[TBL] [Abstract][Full Text] [Related]
56. Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD.
Hartjes FJ; Vonk JM; Faiz A; Hiemstra PS; Lapperre TS; Kerstjens HAM; Postma DS; van den Berge M;
Respirology; 2018 Nov; 23(11):1023-1031. PubMed ID: 29696728
[TBL] [Abstract][Full Text] [Related]
57. Neutrophil gelatinase-associated lipocalin: a biomarker in COPD.
Eagan TM; Damås JK; Ueland T; Voll-Aanerud M; Mollnes TE; Hardie JA; Bakke PS; Aukrust P
Chest; 2010 Oct; 138(4):888-95. PubMed ID: 20495108
[TBL] [Abstract][Full Text] [Related]
58. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
[TBL] [Abstract][Full Text] [Related]
59. Association between blood pressure, inflammation and spirometry parameters in chronic obstructive pulmonary disease.
Arslan S; Yildiz G; Özdemir L; Kaysoydu E; Özdemir B
Korean J Intern Med; 2019 Jan; 34(1):108-115. PubMed ID: 30428648
[TBL] [Abstract][Full Text] [Related]
60. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
